| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.20 | $66.08 (0%) | 🛒 Add to cart |
| 60 | $1.79 | $132.15 $107.12 (19%) | 🛒 Add to cart |
| 90 | $1.64 | $198.23 $147.17 (26%) | 🛒 Add to cart |
| 120 | $1.57 | $264.30 $188.22 (29%) | 🛒 Add to cart |
| 180 | $1.50 | $396.46 $269.31 (32%) | 🛒 Add to cart |
| 270 | $1.45
Best per pill | $594.68 $390.45 (34%) | 🛒 Add to cart |
Synonyms | |||
Similar products
More info:
rosuvastatin
Rosuvastatin represents one of the most significant advances in cardiovascular pharmacotherapy over the past two decades. As a third-generation statin, it offers a unique pharmacological profile that distinguishes it from earlier agents like atorvastatin and simvastatin. In my lipid clinic, we’ve moved beyond simply viewing it as “another statin” and now understand its specific role in managing complex dyslipidemias. The molecule’s distinctive characteristics—particularly its hydrophilicity and potent LDL-C reduction capabilities—make it particularly valuable in clinical scenarios where other statins might fall short or cause unacceptable side effects.
Atorlip 10: Effective Cholesterol Management for Cardiovascular Health - Evidence-Based Review
Before we get to the formal monograph, let me give you the real story on Atorlip 10. When our team first started working on this generic atorvastatin formulation back in 2018, we had three pharmacists and two physicians arguing constantly about the excipient matrix. Dr. Chen kept insisting we needed the full patented crystalline form, while our lead formulator Maria argued that the amorphous dispersion technology would give us comparable bioavailability at half the production cost.
Atorlip 20: Effective Cholesterol Management for Cardiovascular Risk Reduction - Evidence-Based Review
Atorlip 20 represents a significant advancement in lipid management therapy, specifically formulated as a 20mg atorvastatin tablet for patients requiring moderate-intensity statin treatment. Having prescribed various statins over fifteen years of cardiology practice, I’ve observed how this particular dosage often becomes the therapeutic sweet spot for many patients - effective enough to achieve LDL-C targets without pushing into the high-intensity range where side effects become more problematic. The development team actually debated extensively about whether to launch with 10mg or 20mg as the entry formulation, with the clinical research division arguing that starting at 20mg would help more patients reach guideline-directed goals faster.
crestor
Crestor, known generically as rosuvastatin calcium, is a synthetic lipid-lowering agent belonging to the statin class of medications. Marketed globally by AstraZeneca, this HMG-CoA reductase inhibitor represents one of the most potent prescription medications available for managing dyslipidemia. Unlike many dietary supplements, Crestor undergoes rigorous pharmaceutical manufacturing processes and requires physician supervision due to its potent systemic effects and potential side effect profile. ## 1. Introduction: What is Crestor? Its Role in Modern Medicine
diltiazem
Diltiazem hydrochloride - a calcium channel blocker that’s been in our arsenal since the 1980s, yet I still find myself explaining its nuances to residents and patients alike. This benzothiazepine derivative remains one of our most versatile cardiovascular agents, though its mechanisms extend beyond what many clinicians realize. Diltiazem: Comprehensive Cardiovascular Protection Through Calcium Channel Blockade - Evidence-Based Review 1. Introduction: What is Diltiazem? Its Role in Modern Medicine Diltiazem belongs to the benzothiazepine class of calcium channel blockers, specifically acting on L-type calcium channels in vascular smooth muscle and cardiac tissue.
lipitor
Lipitor, known generically as atorvastatin calcium, represents one of the most significant advancements in cardiovascular pharmacotherapy over the past three decades. As a synthetic HMG-CoA reductase inhibitor, this pharmaceutical agent has fundamentally transformed lipid management strategies and secondary prevention protocols. When I first encountered Lipitor in clinical trials during the late 1990s, our cardiology department was skeptical about whether it could outperform existing statins—we’d seen many promising compounds fail to deliver meaningful clinical benefits beyond laboratory parameters.
Pravachol: Effective Cholesterol Management and Cardiovascular Risk Reduction - Evidence-Based Review
Pravastatin sodium, the active pharmaceutical ingredient in Pravachol, represents one of the earliest statin medications developed for managing cholesterol levels. Originally isolated from the fungus Nocardia autotrophica, this hydrophilic compound has been prescribed for decades with a well-established safety and efficacy profile. Unlike some newer agents, pravastatin’s water-soluble nature gives it distinct pharmacokinetic properties that influence both its effectiveness and side effect profile. 1. Introduction: What is Pravachol? Its Role in Modern Medicine What is Pravachol exactly?
rulide
Rulide, known generically as roxithromycin, is a semi-synthetic macrolide antibiotic derived from erythromycin. It’s classified as an azalide due to its nitrogen-containing 14-membered ring structure, which gives it distinct pharmacokinetic advantages over earlier macrolides. In clinical practice since the late 1980s, Rulide occupies an important niche in treating respiratory tract infections, particularly where penicillin allergies or atypical pathogens are concerns. The drug’s extended half-life and tissue penetration make it particularly valuable for once-daily dosing regimens, though its use has become more nuanced with growing antibiotic resistance patterns.
Sustiva: Potent HIV-1 Viral Suppression with CNS Penetration - Evidence-Based Review
Sustiva is a third-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination antiretroviral therapy for HIV-1 infection. It’s one of those foundational antiretrovirals that completely changed our approach to HIV management back in the late 90s - we went from watching patients deteriorate to actually managing a chronic condition. The drug’s unique pharmacokinetic profile allows for once-daily dosing, which dramatically improved adherence rates compared to the complex multi-dose regimens we used to struggle with.